Cargando…
Double-blind, placebo-controlled study of HGF gene therapy in diabetic neuropathy
OBJECTIVE: To evaluate the safety and efficacy of a plasmid (VM202) containing two human hepatocyte growth factor isoforms given by intramuscular injections in patients with painful diabetic neuropathy. METHODS: In a double-blind, placebo-controlled study, patients were randomized to receive injecti...
Autores principales: | Kessler, John A, Smith, A Gordon, Cha, Bong-Soo, Choi, Sung Hee, Wymer, James, Shaibani, Aziz, Ajroud-Driss, Senda, Vinik, Aaron |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4435702/ https://www.ncbi.nlm.nih.gov/pubmed/26000320 http://dx.doi.org/10.1002/acn3.186 |
Ejemplares similares
-
Gene therapy for diabetic peripheral neuropathy: A randomized, placebo‐controlled phase III study of VM202, a plasmid DNA encoding human hepatocyte growth factor
por: Kessler, John A., et al.
Publicado: (2021) -
A randomized, double-blind, placebo-controlled study of histone deacetylase type 6 inhibition for the treatment of painful diabetic peripheral neuropathy
por: Michelson, David, et al.
Publicado: (2023) -
Na(V) channel variants in patients with painful and nonpainful peripheral neuropathy
por: Wadhawan, Samir, et al.
Publicado: (2017) -
An Open Label Exploratory Clinical Trial Evaluating Safety and Tolerability of Once-Weekly Prednisone in Becker and Limb-Girdle Muscular Dystrophy
por: Zelikovich, Aaron S., et al.
Publicado: (2022) -
Nerve Growth Factor and Diabetic Neuropathy
por: Pittenger, Gary, et al.
Publicado: (2003)